How Much Does Jatenzo Cost in Louisiana in 2026?

Louisiana Retail Cash Price for Jatenzo

The cash-pay price for a 30-day supply of Jatenzo at Louisiana retail pharmacies averages $900 in 2026, tracking almost exactly with the manufacturer list price set by Tolmar Pharmaceuticals. Prices vary modestly across chains: some Baton Rouge and New Orleans locations may quote $870 to $940 depending on dose strength and inventory sourcing.

Jatenzo (oral testosterone undecanoate) was approved by the FDA in March 2019 as the first oral testosterone replacement therapy for adult men with hypogonadism. The key registration trial by Swerdloff et al. (2020) enrolled 166 hypogonadal men and demonstrated that 87% of patients achieved average serum testosterone concentrations within the normal range (300 to 1 to 100 ng/dL) by day 90. The drug is dosed as a soft-gelatin capsule taken twice daily with meals, because fat content in food increases absorption of the lipophilic testosterone undecanoate molecule by roughly threefold, per pharmacokinetic data in the FDA label.

GoodRx and similar discount aggregators sometimes bring the price down by $30 to $80 per fill in Louisiana. That still leaves patients paying north of $800 per month out of pocket. For men whose testosterone prescriptions have historically been $30 to $60 generic injectable cypionate fills, the sticker shock is real.

Louisiana Medicaid Does Not Cover Jatenzo

Louisiana Medicaid's preferred drug list excludes Jatenzo as of the most recent formulary update. The state Medicaid program covers injectable testosterone cypionate and topical testosterone gel (generic formulations), but branded oral testosterone undecanoate has not been added to the formulary.

Patients enrolled in Louisiana Medicaid managed-care organizations (MCOs) such as Healthy Blue, AmeriHealth Caritas, Aetna Better Health, Louisiana Healthcare Connections, or UnitedHealthcare Community Plan will find the same exclusion. A non-formulary exception request is theoretically possible, but approval rates for branded testosterone products when generic injectable alternatives exist are low. The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism does not specify a preferred route of administration, which makes medical-necessity arguments for the oral formulation difficult to win at the prior-authorization level.

If your provider is willing to document injection intolerance, needle phobia with documented psychiatric basis, or a contraindication to topical formulations (such as risk of transference to household contacts), those clinical reasons strengthen an exception request. Success is not guaranteed, but documented clinical rationale is the minimum threshold.

Which Commercial Insurers Cover Jatenzo in Louisiana?

Coverage among employer-sponsored and marketplace plans in Louisiana is mixed. The pattern follows national formulary tiering.

Blue Cross Blue Shield of Louisiana places Jatenzo on Tier 3 (preferred brand) for some group plans and Tier 4 (non-preferred brand) for others. Both require prior authorization confirming a diagnosis of hypogonadism with two morning serum testosterone values below 300 ng/dL, consistent with Endocrine Society guideline criteria. Tier 3 copays typically run $50 to $75; Tier 4 runs $100 to $200 before the Tolmar savings card is applied.

UnitedHealthcare commercial plans in Louisiana generally cover Jatenzo under specialty-tier benefits with step therapy requiring prior trial and failure of at least one topical testosterone product. Cigna and Aetna commercial plans have similar step-therapy requirements statewide.

Plans purchased through the Louisiana Health Insurance Marketplace (healthcare.gov) vary by metal level. Silver and Gold plans from BCBSLA and Vantage Health Plan may cover Jatenzo with prior authorization, but Bronze plans often impose coinsurance of 30% to 50% on branded specialty drugs, which on a $900 list price means $270 to $450 per month before any manufacturer assistance.

Contact your insurer's pharmacy benefits line directly and ask for the specific prior-authorization criteria. Having the PA criteria printed in front of your prescriber saves time and rejected claims.

How the Tolmar Savings Card Works in Louisiana

Tolmar, the manufacturer of Jatenzo, offers a copay savings card that reduces out-of-pocket costs for commercially insured patients. The card covers up to $500 in copay or coinsurance costs per 30-day fill, and it is reusable for up to 12 fills per calendar year.

Eligibility rules are straightforward but strict. You must have commercial insurance that covers Jatenzo (even partially). Patients with government-funded insurance (Medicaid, Medicare, Tricare, VA) are excluded by federal anti-kickback statute requirements. Cash-pay patients without any insurance coverage are also ineligible for the standard copay card, though Tolmar operates a separate patient-assistance program for uninsured patients who meet income thresholds.

To activate the card in Louisiana, patients can enroll online at the Tolmar Jatenzo savings program website or call the number on the Jatenzo prescribing information. The pharmacy processes the savings card as a secondary payer at the point of sale. If your commercial plan's copay for Jatenzo is $150, the card covers that $150 entirely. If your coinsurance is $400, the card covers $400. If the coinsurance exceeds $500, you pay the remainder.

One practical note: some Louisiana pharmacy benefit managers (PBMs) require the savings card BIN and PCN numbers to be entered manually. Ask your pharmacist to process the card as a secondary claim rather than a primary, or the adjudication may reject.

Compounded Oral Testosterone Undecanoate in Louisiana

Louisiana permits licensed 503A compounding pharmacies to prepare oral testosterone undecanoate capsules pursuant to a valid patient-specific prescription. This is legal under both federal law (section 503A of the Federal Food, Drug, and Cosmetic Act) and Louisiana Board of Pharmacy regulations.

The cost difference is dramatic. Compounded oral testosterone undecanoate from a Louisiana 503A pharmacy may cost between $60 and $180 per month depending on the compounding pharmacy, dose, and whether the patient uses a local brick-and-mortar compounder or a mail-order 503A pharmacy licensed to ship into Louisiana. Some telehealth-and-compounding clinic models bundle the prescriber visit and compounded medication for a flat monthly fee that undercuts the branded product by 80% or more.

There are tradeoffs. Compounded products are not FDA-approved, are not subject to the same bioequivalence testing as Jatenzo, and may vary in absorption characteristics. The FDA has noted that compounded drugs do not undergo the premarket safety and efficacy review that approved drugs receive. Testosterone undecanoate absorption is highly sensitive to the lipid vehicle used in the capsule formulation; the Jatenzo Self-Emulsifying Drug Delivery System (SEDDS) was specifically engineered to optimize bioavailability. A compounded capsule using a different oil base may yield different serum testosterone levels at the same milligram dose.

For patients who cannot afford $900 per month and lack insurance coverage, compounding is a financially viable route. Discuss monitoring expectations with your prescriber: more frequent serum testosterone trough checks (at 4 and 8 weeks after starting) are reasonable when switching to or initiating a compounded formulation to confirm adequate absorption.

Telehealth Prescribing of Jatenzo in Louisiana

Louisiana allows telehealth prescribing of Jatenzo. The state's telehealth parity law, updated in 2020, permits physicians and advanced practice providers to prescribe Schedule III controlled substances (testosterone is Schedule III) via audio-video telehealth encounters, provided the prescriber holds an active Louisiana medical license or is practicing under an interstate compact.

Several national men's health telehealth platforms operate in Louisiana and prescribe Jatenzo or compounded oral testosterone undecanoate. The typical workflow involves completing an online intake, uploading recent lab work (or ordering labs through the platform's partnered lab network), and a synchronous video visit with a licensed provider.

Telehealth visits for testosterone therapy in Louisiana generally cost $99 to $199 for the initial consultation and $49 to $99 for follow-up visits. Some platforms bundle the visit fee into a monthly subscription that includes the compounded medication. If you specifically want brand-name Jatenzo, confirm that the telehealth platform will send the prescription to your preferred retail or specialty pharmacy, because some platforms default to their affiliated compounding pharmacy.

Lab monitoring on oral testosterone undecanoate should include a complete metabolic panel, lipid panel, hematocrit, and PSA per Endocrine Society recommendations. The Swerdloff et al. registration trial observed that oral testosterone undecanoate produced a modest increase in systolic blood pressure (mean 3 to 5 mmHg) compared to placebo, which the FDA flagged as a labeled precaution. Home blood pressure monitoring is a sensible addition to your follow-up plan, and telehealth visits are well-suited for reviewing those readings.

How to Reduce Your Jatenzo Cost in Louisiana

Start with insurance verification. Call the number on the back of your insurance card and ask: "Is Jatenzo (oral testosterone undecanoate) on my formulary, and what is the prior-authorization requirement?" That single call determines your next move.

If Jatenzo is covered, apply the Tolmar savings card. For a patient with a $150 copay, the savings card drops the cost to $0. For a patient with $350 coinsurance, it drops to $0. For coinsurance above $500, you pay the overage.

If Jatenzo is not covered or you are uninsured, your best options in Louisiana are:

1. Request a non-formulary exception from your insurer with documented clinical justification (injection intolerance, transference risk, or documented adherence failure on topical testosterone).
2. Apply to the Tolmar patient-assistance program if household income is below 400% of the federal poverty level.
3. Use a licensed 503A compounding pharmacy in Louisiana for oral testosterone undecanoate at $60 to $180 per month.
4. Consider whether injectable testosterone cypionate ($30 to $60 per month at most Louisiana pharmacies) meets your clinical needs. It is the most commonly prescribed testosterone formulation in the United States and is covered by Louisiana Medicaid.

As Dr. Ronald Swerdloff, lead investigator of the Jatenzo registration trial, noted in a 2020 commentary: "The availability of an oral testosterone that achieves normal-range serum levels without first-pass liver toxicity represents a meaningful advance for patients who cannot or will not use injections or gels." The clinical value is established. The access question is financial.

Jatenzo vs. Injectable Testosterone: Cost Comparison in Louisiana

The cost gap between Jatenzo and injectable testosterone cypionate in Louisiana is roughly 15-fold. Generic testosterone cypionate 200 mg/mL (10 mL vial) costs $30 to $60 cash at Louisiana retail pharmacies and is universally covered by Medicaid, Medicare, and commercial plans with minimal or no prior authorization.

Jatenzo's clinical profile does offer advantages that may justify the premium for specific patients. The Swerdloff et al. trial showed that oral testosterone undecanoate maintained eugonadal testosterone levels (average Cavg 489 ng/dL) with twice-daily oral dosing, eliminating the peaks and troughs associated with weekly or biweekly intramuscular injections. Hematocrit elevation, a known risk with exogenous testosterone, occurred in 3.5% of oral testosterone undecanoate patients in the registration trial versus rates of 5% to 14% reported in injectable testosterone studies.

For Louisiana patients weighing cost against convenience, the decision framework is simple. If you tolerate injections, the injectable route saves $840 or more per month. If needles are a barrier to adherence, and insurance plus the savings card brings your Jatenzo copay below $75, the oral route becomes financially reasonable. If you fall between those scenarios, compounded oral testosterone undecanoate from a Louisiana 503A pharmacy at $60 to $180 per month occupies the middle ground.

The Louisiana Board of Pharmacy maintains a public license verification portal where you can confirm that any compounding pharmacy you are considering holds a valid 503A permit. Verify before you fill.